December 26, 2025

EyePoint, Inc. (EYPT) Stock Analysis: A Potential 97% Upside with an Eye on Biotech Innovations

EyePoint, Inc. (NASDAQ: EYPT) stands as a compelling opportunity in the biotechnology sector, promising significant potential upside for astute investors. With a market capitalization of $1.51..

SIGA Technologies Inc. (SIGA): Investor Outlook with Strong Forward P/E as a Highlight

SIGA Technologies Inc. (NASDAQ: SIGA) stands out in the healthcare sector as a commercial-stage pharmaceutical company with a targeted focus on the health security market. Headquartered..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Volatility with a 19.72% Upside Potential

For investors keeping a close eye on the biotechnology sector, Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) presents an intriguing mix of innovation and volatility. As a..

Orthofix Medical Inc. (OFIX) Investor Outlook: Analyzing the 50.40% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX) stands at a fascinating crossroads for investors, blending its robust presence in the healthcare sector with a strategic focus on medical..

Precigen, Inc. (PGEN) Stock Analysis: A Biotech Play with Over 100% Upside Potential

Precigen, Inc. (NASDAQ: PGEN) is making waves in the biotechnology sector with its innovative gene and cell therapy platforms. Based in Germantown, Maryland, this clinical-stage biopharmaceutical..

Replimune Group, Inc. (REPL) Investor Outlook: Navigating Biotech Potential with a 24.59% Upside

Replimune Group, Inc. (NASDAQ: REPL) is garnering attention in the biotechnology sector with its promising oncolytic immunotherapy product candidates aimed at treating cancer. This clinical-stage company,..

Talkspace, Inc. (TALK) Investor Outlook: Analysts Predict a 33% Upside for This Healthcare Innovator

In the rapidly evolving healthcare sector, Talkspace, Inc. (NASDAQ: TALK) stands out as a forward-thinking player in the field of mental health services. With a market..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Volatility with a 20.48% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN) offers a comprehensive range of talent management services for healthcare clients across the United States. With a market capitalization of..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 131% Potential Upside

LifeMD, Inc. (NASDAQ: LFMD), a dynamic player in the healthcare sector, is capturing the attention of investors with its robust telehealth services and significant growth potential...

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: A 46% Upside Potential Amid Strong Buy Ratings

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) has been capturing the attention of investors with its significant potential upside and unanimous buy ratings from analysts. As a clinical-stage..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: 76.57% Upside Potential and Robust Revenue Growth

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a promising player in the healthcare sector, has caught the attention of investors with its impressive revenue growth and substantial upside..

Personalis, Inc. (PSNL) Stock Analysis: Exploring a 30.8% Potential Upside in the Healthcare Sector

For investors with a keen eye on the healthcare sector, Personalis, Inc. (NASDAQ: PSNL) presents a compelling opportunity, underscored by a potential upside of 30.8% based..

Semler Scientific (SMLR) Stock Analysis: A Deep Dive into Its 278% Potential Upside

Semler Scientific, Inc. (SMLR), a U.S.-based provider of medical devices, is currently trading at $17.35, presenting a compelling opportunity for investors seeking high growth potential in..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: Uncovering a Potential 131.77% Upside in Biotech Innovation

Day One Biopharmaceuticals, Inc (NASDAQ: DAWN) is a compelling entity in the biotechnology sector, with its focus sharply tuned towards developing revolutionary treatments for both childhood..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Biotech Innovator with a 13.50% Upside Potential

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is making waves in the biotechnology sector with a promising portfolio of immunology-based therapies. As a clinical-stage biopharmaceutical company, Zenas BioPharma..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Investment Opportunities in the Healthcare Sector

Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector, is garnering investor attention with its specialized focus on home health and hospice services in..

COMPASS Pathways Plc (CMPS) Stock Analysis: A 145% Upside Potential in the Mental Health Revolution

For investors with a keen eye on the burgeoning healthcare sector, COMPASS Pathways Plc (NASDAQ: CMPS), a trailblazer in mental health treatment innovation, presents a compelling..

Definitive Healthcare Corp. (DH) Investor Outlook: Potential 43% Upside Amid Challenging Metrics

Definitive Healthcare Corp. (NASDAQ: DH) is a notable player in the health information services industry, carving its niche by offering a comprehensive software-as-a-service (SaaS) healthcare commercial..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Exploring Growth Potential with a Robust Pipeline in Cystic Fibrosis Treatment

Sionna Therapeutics, Inc. (SION), a clinical-stage biopharmaceutical company focused on innovative therapies for cystic fibrosis (CF), has garnered significant attention from investors. With a market capitalization..

Search

Funds

December 26, 2025

Search

Funds

December 26, 2025

FTSE 100

Funds